摘要
目的 探讨西洛他唑对糖尿病 (DM)大鼠黏附分子CD54、CD10 6、CD62p的表达和坐骨神经传导速度及对肾脏以及主动脉病变的影响。方法 实验设正常组 8只大鼠 ,糖尿病组 8只大鼠 ,胰岛素组 7只大鼠和西洛他唑组 7只大鼠。测定各组坐骨神经传导速度 ,单个核细胞表面CD54、血小板表面CD62p以及肾脏、主动脉CD54或CD10 6的表达水平。结果 西洛他唑明显加快坐骨神经传导速度 (DM组 2 0 3m·s-1± 2 2m·s-1,西洛他唑组 2 8 9m·s-1± 7 9m·s-1,P <0 0 5 )。降低单个核细胞表面CD54的表达 (DM =6 5 1%± 14 9% ,西洛他唑组 2 5 4 %± 8 6 % ,P <0 0 5 ) ,减少肾脏和主动脉CD54和CD10 6表达 ,改善肾脏和主动脉病理变化。而降低血小板表面CD62p的作用不明显 (DM组 4 0 4 %±8 7% ,西洛他唑组 2 8 5 %± 3 7% ,P >0 0 5 )。结论 西洛他唑能降低CD54、CD10 6的表达 。
Objective To investigate the effect of cilostazol on the expression of CD 54 , CD 106 , CD 62P in kidney, aorta, surface of platelet, and mononuclear cell of blood in STZ induced diabetic rats Methods Rats were randomly divided into four groups: normal control group( n =8), diabetes control group( n =8), insulin group( n =7, subcutaneous injection of insulin, 1~4 U·d -1 ), and cilostazol group( n =7, gastric infusion of cilostazol, 18 mg·kg -1 ·d -1 ) Sciatic nerve conductive velocity and level of CD 54 /CD 62p on the surface of mononuclear cell/platelet were examined by flow cytometry Immunohistochemistry was used to examine the expression of CD 54 and/or CD 106 in kidney and aorta Results The sciatic nerve conductive velocity was 20 3±2 2 m·s -1 and 28 9±7 9 m·s -1 in diabetic rats and cilostazol group respectirely ( P <0 05) The mononuclear cell surface expression of CD 54 was 69 1±14 9% and 25 9±8 6% in diabetic group and cilostazol group respectively ( P <0 05) The expression of CD 54 /CD 106 in kidney and aorta was decreased The expression of CD 62p on the surface of platelets was 40 4±8 7% in diabetic group and 28 5±3 7% in cilostazol group ( P >0 05) Conclusion Cilostazol treatment delays the development of diabetic pathological change in kidney, aorta and sciatic nerve and decreases the expression of CD 54 and CD 106
出处
《中华医学杂志》
CAS
CSCD
北大核心
2002年第11期729-731,共3页
National Medical Journal of China
基金
山东省科技厅资助项目 (1999BBB1DBAAA)